Global Retirement Partners’s Heron Therapeutics HRTX Stock Holding History

Global Retirement Partners’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.72K	Buy	+4,018	New	+$3.22K	﹤0.01%	4083
2025 Q4	$5.22K	Hold	4,018	–	–	﹤0.01%	3426
2025 Q3	$5.06K	Hold	4,018	–	–	﹤0.01%	2972
2025 Q2	$8.32K	Buy	+4,018	New	+$8.21K	﹤0.01%	2695
2024 Q4	$6.15K	Hold	4,018	–	–	﹤0.01%	2593
2024 Q3	$8K	Hold	4,018	–	–	﹤0.01%	2378
2024 Q2	$14.1K	Buy	4,018 +18	+0.5%	+$55	﹤0.01%	2159
2024 Q1	$11.1K	Hold	4,000	–	–	﹤0.01%	2078
2023 Q4	$8.8K	Hold	4,000	–	–	﹤0.01%	2118
2023 Q3	$3.84K	Hold	4,000	–	–	﹤0.01%	2281
2023 Q2	$4.64K	Buy	4,000 +2,000	+100%	+$3.57K	﹤0.01%	2233
2023 Q1	$4.66K	Buy	+2,000	New	+$5.01K	﹤0.01%	2185

Other funds holding HRTX

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Global Retirement Partners's HRTX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Heron Therapeutics (HRTX) in Q2 2026: 4,018 shares worth $1.72K. The stake represents ﹤0.01% of the portfolio and ranks #4083 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in HRTX as recently as Q4 2025.

Global Retirement Partners first reported a position in HRTX in Q1 2023 and has held it in 12 quarters since. The position peaked at $14.1K in Q2 2024. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

Global Retirement Partners held 4,018 shares of Heron Therapeutics worth $1.72K as of Q2 2026.
Heron Therapeutics was a new Global Retirement Partners position in Q2 2026.
Heron Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4083 holding.
Global Retirement Partners first reported a position in Heron Therapeutics in Q1 2023 and has held it in 12 quarters since.
Global Retirement Partners's Heron Therapeutics position peaked at $14.1K in Q2 2024.
163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.